| Financial Year |
March 31 2023 |
| Monetary Funds |
1,025,538,899.89 |
| Held-for-trading Financial Assets |
400,600,542.78 |
| Notes Receivable |
50,000.00 |
| Accounts Receivable |
146,380,017.51 |
| Advances to Suppliers |
181,282,785.91 |
| Other Receivables |
27,690,548.47 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
42,763,565.43 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
62,404,383.76 |
| Total Current Assets |
1,888,860,054.36 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,207,966,053.61 |
| Investment Properties |
-- |
| Fixed Assetes |
2,202,954,274.63 |
| Under-construction Projects |
842,895,850.64 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
177,840,850.59 |
| R&D expenses |
-- |
| Goodwill |
81,121.63 |
| Long-Term Deferred and Prepaid Expenses |
1,272,807.36 |
| Deferred Income Tax Assets |
2,836,685.89 |
| Other Non-Current Assets |
92,354,962.25 |
| Sub-Total of Non-Current Assets |
4,605,577,440.32 |
| Total Assets |
6,494,437,494.68 |
| Short-Term Loans |
230,034,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
229,189,643.32 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
15,607,081.18 |
| Taxes Payable |
44,401,586.43 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
155,650,964.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
47,982,969.49 |
| Other Current Liabilities |
16,596,466.55 |
| Sub-Total of Current Liabilities |
928,971,651.38 |
| Long-term Loans |
1,487,946,576.17 |
| Bonds Payable |
900,338,042.81 |
| Long-Term Accounts Payable |
2,195,188.55 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
527,114.31 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,396,025,783.61 |
| Total Liabilities |
3,324,997,434.99 |
| Paid-In Capital(Or Share Stock) |
478,223,503.00 |
| Capital Surplus |
891,387,914.47 |
| Surplus Reserve |
141,657,553.94 |
| LESS:Treasury Stock |
37,594,960.00 |
| Undistributed Profits |
1,279,552,215.95 |
| Minority Stockholder's Interest |
285,938,448.82 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,883,501,610.87 |
| Owner's Equity（Stockholder's Equity） |
3,169,440,059.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,494,437,494.68 |
